Benitec Biopharma Inc. (BNTC): Depreciation & Amortization
$58.0K
Year ended 2026-06-30
-24.7%
3-year compound annual growth
-24.1%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $58.0K | -12.1% | 2026-09-14, From 2025-07-01 |
| 2025-06-30 | $66.0K | -24.1% | 2026-09-14, From 2024-07-01 |
| 2024-06-30 | $87.0K | -36.0% | 2026-03-20, From 2023-07-01 |
| 2023-06-30 | $136.0K | -18.6% | 2024-09-26, From 2022-07-01 |
| 2022-06-30 | $167.0K | -27.7% | 2023-09-21, From 2021-07-01 |
| 2021-06-30 | $231.0K | +21.6% | 2022-09-02, From 2020-07-01 |
| 2020-06-30 | $190.0K | +20.3% | 2021-09-20, From 2019-07-01 |
| 2019-06-30 | $158.0K | n/a | 2020-09-23, From 2018-07-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Benitec Biopharma Inc. (BNTC) | 2026-06-30 | $58.0K | -12.1% |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 2025-12-31 | $621.0K | +16.3% |
| PepGen Inc. (PEPG) | 2025-12-31 | $1.40M | -6.7% |
| Adicet Bio, Inc. (ACET) | 2025-12-31 | $6.38M | -1.3% |
| Trevi Therapeutics, Inc. (TRVI) | 2025-12-31 | $144.0K | -2.0% |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | $24.0K | -97.1% |
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | $3.33M | +6.8% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | 2025-12-31 | $233.0K | -60.4% |
| Climb Bio, Inc. (CLYM) | 2025-12-31 | $97.0K | n/a |
Compare BNTC, LXRX, PEPG, ACET side by side · Screen every company in Pharmaceutical Preparations ↗